|
3376.0: Monday, November 8, 2004: 8:30 PM-10:00 PM | |||
Oral | |||
| |||
HIV/AIDS co-morbidity with TB and malaria have been a challenge for HIV/AIDS providers here in the United States and detrimental to the chance of survival for those affected with HIV/AIDS in developing countries. This session will highlight innovative attempts to address care, treatment, and financing challenges associated with HIV/AIDS, TB, and malaria programs in developing countries, and will point to ways in which countries can better implement programs. | |||
Learning Objectives: Participants will learn about forecasting ACT and HIV/AIDS financing, beneficial treatment regimens to avoid drug resistance, monitoring funding and disbursements, increasing case detection and strengthening case management. | |||
Ann McCauley, PhD | |||
Introductory Remarks | |||
Use of incentives to improve performance of national TB programs in Latin America and the Caribbean Melissa Thumm, Alix Beith | |||
Modeling financial requirements of artemisinin-based combination therapies of anti-malarial drug treatments in sub-saharan africa Yann Derriennic, Beaura Mensah | |||
Monitoring the disbursement of funding for HIV/AIDS services in Rwanda; Findings from National Health Accounts Susna R De, MSc, MPH, Catherine Chanfreau, MD, MPH, Owen Smith, MPA, Pia Schneider, MA, Desire Ndushabandi, MD | |||
Implementing artemisinin-based combination therapy in malaria endemic areas of Africa Brigg Reilley, MPH | |||
Use of information to increase case detection and strengthen case management of TB/HIV co-morbidity Caroline Quijada, MHS | |||
Concluding Remarks | |||
See individual abstracts for presenting author's disclosure statement and author's information. | |||
Organized by: | International Health | ||
Endorsed by: | HIV/AIDS; Health Administration; Population, Family Planning, and Reproductive Health; Public Health Education and Health Promotion | ||
CE Credits: | CME, Health Education (CHES), Nursing |